Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año2015201620172018201920202021202220232024 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialLetterProceedings PaperReprintReview Revista EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci Autores: Hidalgo-Tenorio, C; Sadyrbaeva-Dolgova, S; Enríquez-Gómez, A; Muñoz, P; Plata-Ciezar, A; Miró, JM; Alarcón, A; Martínez-Marcos, FJ; Loeches, B; Escrihuela-Vidal, F; Vinuesa, D; Herrero, C; Boix-Palop, L; Arenas, MD; Vázquez, EG; de las Revillas, FA Ceft-to-Ceft Study: Real-Life Experience with Ceftaroline and Ceftobiprole in Treatment of the Principal Infectious Syndromes in a Spanish Multicenter Hospital Cohort Autores: García, DA; Pitto-Robles, I; Parra, JC; Salvador, MC; Rodríguez, CH; Gisbert, L; Hidalgo-Tenorio, C Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis Autores: Kabra, M; Barber, TJ; Allavena, C; Marcelin, AG; Di Giambenedetto, S; Pasquau, J; Gianotti, N; Llibre, JM; Rial-Crestelo, D; De Miguel-Buckley, R; Blick, G; Turner, M; Harrison, C; Wynne, T; Verdier, G; Parry, CM; Jones, B; Okoli, C; Donovan, C; Priest, J Ceft-to-Ceft Study: Real-Life Experience with Ceftaroline and Ceftobiprole in Treatment of the Principal Infectious Syndromes in a Spanish Multicenter Hospital Cohort Autores: Herrera-Hidalgo, L; Muñoz, P; Alvarez-Uría, A; Alonso-Menchén, D; Luque-Marquez, R; Gutiérrez-Carretero, E; Fariñas, MD; Miró, JM; Goenaga, MA; López-Cortés, LE; Angulo-Lara, B; Boix-Palop, L; de Alarcón, A Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia: Post-Hoc Analysis of a Multicenter Observational Cohort Autores: Castillo-Fernández, N; Pérez-Crespo, PMM; Salamanca-Rivera, E; Herrera-Hidalgo, L; de Alarcón, A; Navarro-Amuedo, MD; Ciordia, TM; Pérez-Rodríguez, MT; Sevilla-Blanco, J; Jover-Saenz, A; Fernández-Suárez, J; Armiñanzas-Castillo, C; Reguera-Iglesias, JM; K Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies Autores: Wei, FX; Goodman, MT; Xia, NS; Zhang, J; Giuliano, AR; D'Souza, G; Hessol, NA; Van der Loeff, MFS; Dai, JH; Neukam, K; De Pokomandy, A; Poynten, IM; Geskus, RB; Burgos, J; Etienney, I; Moscicki, AB; Don, MG; Gillison, ML; Nyitray, AG; Nowak, RG; Yunihastu Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial Autores: Trigo-Rodríguez, M; Cárcel, S; Navas, A; Espíndola-Gómez, R; Garrido-Gracia, JC; Moreno, MAE; León-López, R; Pérez-Crespo, PMM; Alonso, EA; Vinuesa, D; Romero-Palacios, A; Pérez-Camacho, I; Gutiérrez-Gutiérrez, B; Martínez-Marcos, FJ; Fernández-Roldán, C; < 1 2 … 295 296 297 … 1.504 1.505 >